This echoes arguments made by drug firms against makers of generic drugs. (Never mind that innovation in software tends to occur in universities and start-ups, not big firms.) Microsoft is advancing it through a lobby group, the Initiative for Software Choice, hoping to dissuade governments from using open-source software.

ECONOMIST: Software